✦ LIBER ✦

Increased Expression of Plasminogen Activator Inhibitor-1 in Cardiomyocytes Contributes to Cardiac Fibrosis after Myocardial Infarction

✍ Scribed by Kyosuke Takeshita; Mutsuharu Hayashi; Shigeo Iino; Takahisa Kondo; Yasuya Inden; Mitsunori Iwase; Tetsuhito Kojima; Makoto Hirai; Masafumi Ito; David J. Loskutoff; Hidehiko Saito; Toyoaki Murohara; Koji Yamamoto

Book ID: 117021504
Publisher: American Society for Investigative Pathology
Year: 2004
Tongue: English
Weight: 871 KB
Volume: 164
Category: Article
ISSN: 0002-9440
DOI: 10.1016/s0002-9440(10)63135-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Downregulated Expression of Plasminogen

Downregulated Expression of Plasminogen Activator Inhibitor-1 Augments Myocardial Neovascularization and Reduces Cardiomyocyte Apoptosis After Acute Myocardial Infarction

✍ Guosheng Xiang; Michael D. Schuster; Tetsunori Seki; Piotr Witkowski; Shawdee Es 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Plasminogen Activator Inhibitor-1 Defici

Plasminogen Activator Inhibitor-1 Deficiency and Aging Contribute to Upregulation of Profibrotic Pathways, Cardiac Fibrosis, and Alterations of Myocardial Function in Mice

✍ William Bradham; Linda Gleaves; Mousumi Medda; Douglas Vaughan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9 Plasminogen activator inhibitor-1 geno

9 Plasminogen activator inhibitor-1 genotype and levels in relation to myocardial infarction and extent of coronary atheroma

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Increase of tissue-type plasminogen acti

Increase of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in plasma after thrombolytic therapy of patients with myocardial infarction. A randomised, placebo-controlled study

✍ S. Munkvad; J. Gram; J. Jespersen 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 753 KB

1P-0067 Recurrence of myocardial infarct

1P-0067 Recurrence of myocardial infarction in strongly associated with insulin resistance and increased plasminogen activator inhibitor 1 levels both in type 2 diabetes and nondiabetic patients

✍ Lalic, N.M.; Ostojic, M.; Kanjuh, V.; Lalic, K.; Jotic, A.; Zamaklar, M.; Lukic, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Increase in plasma plasminogen activator

Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene

✍ A. MLYNARSKA; T. WASZYROWSKI; J. D. KASPRZAK 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB